Boxer Capital, Llc Esperion Therapeutics, Inc. (ESPR) insider trading activity

Boxer Capital, LLC is > 10% Shareholder of Esperion Therapeutics, Inc.. Currently has a direct ownership of 1.1 Million shares of ESPR, which is worth approximately $2.78 Million. The most recent transaction as insider was on Nov 05, 2018, when has been sold 60,000 shares (Common Stock) at a price of $57.89 per share, resulting in proceeds of $3,473,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.1M

0% 3M change

0% 12M change

Total Value Held $2.78 Million

Boxer Capital, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Nov 05 2018	SELL Open market or private sale	$3,473,400 $57.89 p/Share	60,000 Reduced 5.17%	1,101,250 Common Stock
Nov 02 2018	SELL Open market or private sale	$2,198,000 $54.95 p/Share	40,000 Reduced 3.33%	1,161,250 Common Stock

Also insider at

MRTX

Mirati Therapeutics, Inc. Healthcare

ODTC

Odonate Therapeutics, Inc. Financial Services

> 10% Shareholder

SLDB

Solid Biosciences Inc. Healthcare

> 10% Shareholder

PAND

Pandion Therapeutics, Inc.

> 10% Shareholder

ITOS

iTeos Therapeutics, Inc. Healthcare

PMVP

PMV Pharmaceuticals, Inc. Healthcare

RAIN

Rain Therapeutics Inc. Healthcare

TYRA

Tyra Biosciences, Inc. Healthcare

TNGX

Tango Therapeutics, Inc. Healthcare

BCL